ReviewEuropean journal of cancer (Oxford, England : 1990)2020

Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.

Dario Pasalic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.